Abstract
First and second generation lipid lowering drugs are discussed concerning their mechanism of action effects on lipoproteins, benefits on fatal and nonfatal coronary disease tended effects and therapeutic uses. Recommendations when to prescribe lipid lowering drugs were based on the new Dutch Cholesterol Consensus (1998) of the Centraal Begeleidingsorgaan vour de Intercollegiale Toetsing. Future developments on identification of patients resistant to lipid lowering drugs are mentioned.
| Translated title of the contribution | On the treshold of knowledge. Pharmacological treatment of hyperlipidaemia |
|---|---|
| Original language | Dutch |
| Pages (from-to) | 1667-1671 |
| Number of pages | 5 |
| Journal | Pharmaceutisch Weekblad |
| Volume | 134 |
| Issue number | 48 |
| Publication status | Published - 3 Dec 1999 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- antilipemic agent
- article
- coronary artery disease
- drug effect
- drug mechanism
- human
- hyperlipidemia
- mortality
Fingerprint
Dive into the research topics of 'On the treshold of knowledge. Pharmacological treatment of hyperlipidaemia'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver